Radboud universitair medisch centrum / RADBOUDUMC — Clinical Trial Site

105 Registered trials

49 Currently recruiting

Organisation

Radboud universitair medisch centrum / RADBOUDUMC

Location

Nijmegen, Netherlands

Identifier

ORG-100031688

Address

Huispost 935, P. O. Box 9101, 6500 HB, Netherlands

Departments

-
#3702: Paediatrics
#3712: Cardiology
1304: Nephrology
1500: Medische Beeldvorming, sectie Nucleaire Geneeskunde
1501 :Medische Beeldvorming, sectie Nucleaire Geneeskunde
3702: Paediatrics
Afdeling Interne Geneeskunde
Amalia Children's Hospital, pediatrics
Anesthesiology
Cardiology
Department of Hematology
Department of Internal Medicine
Department of Surgery
Department Respiratory Diseases
Gastroenterology
Gastroenterology & Hepatology
Gastroenterology and Hepatology
Gynaecologische Oncologie
Hematology
Human Genetics
ICU
Intensive Care
Internal Medicine
Internal Medicine, division Infectious Diseases and Immunology
Laboratory Medical Immunology
Lung Oncology
Maag,- darm,- leverziekten
Medical Biosciences
Medical Imaging, Nuclear Medicine
Medical Oncology
Medische Oncologie
N/A
Nephrology
Neurology
Neuromuscular Unit
Neurosurgery
Nierziekten
NL10010, Maag, darm en leverziekten
Oncology
Ophthalmology
Otorhinolaryngology
Pediatrics
Pharmacy
Psychiatry
Pulmonary Diseases
Pulmonology
RADB
Radiotherapy
Research Facility
Research Unit Longziekten
Respiratory Diseases
Rheumatology
Surgery
Urology
Verloskunde & Gynaecologie
Ward (internal medicine)
Z97NL10002: Hematology

Clinical trials at this site (105)

Search interface

A clinical trial to learn about the effects of YTB in people with difficult to treat active systemic lupus erythematosus (SLE), or active k… Recruiting

2023-510150-17-00 Active, refractory systemic lupus erythematosus (SLE), 4 2024-12-11
Optimizing therapy with n=1-studies: negating the 'nocebo' effect in statin-intolerance Recruiting

2023-507489-20-00 Statin-intolerance 6 2024-12-10
Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting

2024-513092-40-00 Stroke 6 2024-12-05
A Phase I, open-label, multi-center study of radiation dosimetry, safety, and tolerability of extended lutetium (177Lu) vipivotide tetraxeta… Recruiting

2024-512338-13-00 Metastatic Castration-Resistant Prostate Cancer 3 2024-11-11
A phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Can… Recruiting

2023-509340-10-00 Patients with HLA-A2 positive phenotype and metastatic 5 2024-10-29
Can we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemi… Recruiting

2024-514620-17-00 Patients with early-stage rectal cancer (defined as ear 4 2024-10-14
Methylphenidate in KBG syndrome Recruiting

2023-506202-40-01 KBG syndrome 6 2024-10-01
Efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled clinical trial. (EDIT-CAS) Recruiting

2023-507782-25-00 Coronary vasomotor dysfunction (spasm) 10 2024-09-27
Trastuzumab Deruxtecan (T-DXd) for Subjects with Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC0 Breast Cancer… Recruiting

2023-505616-38-00 Unresectable and/or Metastatic HER2-low or HER2 Immunoh 4 2024-09-04
A Study to Evaluate Whether Healing all Bowel Wall Layers is a Superior Treatment Target in Patients with Active Crohn’s Disease (CD). Recruiting

2023-509096-16-00 Moderately to Severely Active Crohn’s Disease 6 2024-07-31
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX versus mFOLFIRINOX Alone in Patients wit… Recruiting

2022-502404-73-00 Pancreatic ductal adenocarcinoma 4 2024-06-03
Drug Rediscovery for rare Immune Mediated Inflammatory Diseases (DRIMID) Recruiting

2022-502968-20-02 Behcet's disease 4 2024-05-30
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezom… Recruiting

2023-507632-20-00 Multiple Myeloma 5 2024-05-01
A phase 2 trial in stage II-IIIa urothelial cancer randomizing pre-operative nivolumab with or without relatlimab - TURANDORELA Recruiting

2023-507460-39-00 Adult patients with resectable muscle-invasive urotheli 10 2024-02-15
PEHAB II Recruiting

2023-507466-40-00 Prostate cancer 6 2024-01-12
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies Recruiting

2023-510541-25-00 Relapsed/Refractory B-cell Malignancies 1 2023-10-09
A study to look at how safe divarasib is when given on its own or in combination with other anti-cancer therapies, and how well these medici… Recruiting

2023-507171-22-00 Untreated Advanced or Metastatic Non-Small Cell Lung Ca 9 2023-06-21
(SPARROW) Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple’s procedure (SPARROW): a … Recruiting

2024-510766-16-00 Pancreatoduodenectomy with a high risk for contaminated 11 2023-03-06
Renal Lifecycle Trial: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in … Recruiting

2023-508389-13-00 Combined endpoint of all-cause mortality, kidney failur 5 2022-11-08
Treatment of opioid dependency in patients with chronic pain: a comparative study between suboxone and methadone. Recruiting

2024-513924-41-01 Opioid use disorder (DSM-5); chronic non-cancer pain (I 6 2022-05-11
Pancreatitis and early omega-3-fatty acid infusion for reduction of organ failure and mortality. Recruiting

2023-505220-57-03 Predicted severe acute pancreatitis 5 2022-05-09
A study of MK-7240/PRA023 in patients with Systemic Sclerosis Associated with Interstitial Lung Disease Recruiting

2023-509743-27-00 Systemic sclerosis associated with interstitial lung di 4 2022-04-29
GROINSS-V III Recruiting

2023-508722-99-00 Vulvar cancer 4 2020-11-19
Multicentre, open-label, randomized, controlled, parallel arms clinical trial of induction chemotherapy followed by chemoradiotherapy versus… Recruiting

2024-512526-28-00 Locally recurrent rectal cancer 5 2020-10-28